A multicenter randomized phase III trial of nonpegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide (MC) versus liposome-encapsulated doxorubicin citrate plus vinorelbine (MV) as first-line treatment in locally advanced (LABC) or metastatic breast cancer (MBC).
2011 ◽
Vol 29
(15_suppl)
◽
pp. 1041-1041
Keyword(s):
2007 ◽
Vol 41
(6)
◽
pp. 555-562
◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. TPS102-TPS102
◽
Keyword(s):
2009 ◽
Keyword(s):
2013 ◽
Keyword(s):
2009 ◽
Vol 7
(2)
◽
pp. 265
◽
Keyword(s):
1999 ◽
Vol 35
◽
pp. S315
◽
Keyword(s):
Keyword(s):